COVID-PACT, 2022
anticoagulant, curative dose vs. anticoagulant, prophylactic dose
COVID-19 severe or critically
REMAP-CAP, ACTIV-4a, ATTACC (critically ill patients), 2021 NCT02735707
anticoagulant, curative dose vs. anticoagulant, prophylactic dose
COVID-19 severe or critically
Tang, 2020
anticoagulant, prophylactic dose vs. control
COVID-19 severe or critically
INSPIRATION, 2021 NCT04486508
anticoagulation, intermediate prophylactic dose vs. anticoagulant, prophylactic dose
COVID-19 severe or critically
NCT04445935, 0 NCT04445935
Bivalirudin vs. standard of care
COVID-19 severe or critically
ATTACC (Houston), 0 NCT04372589
heparin at therapeutic dose vs. control
COVID-19 severe or critically
ACTIV-4a (heparin), 0 NCT04505774
heparin at therapeutic dose vs. control
COVID-19 severe or critically
REMAP-CAP Anticoagulation, 0 NCT02735707
heparin at therapeutic dose vs. control
COVID-19 severe or critically
COVID-19-HBO, 0 NCT04327505
hyperbaric oxygen vs. standard of care
COVID-19 severe or critically
NCT04338802, 0 NCT04338802
nintedanib vs. standard of care
COVID-19 severe or critically
NCT04445623, 0 NCT04445623
P2Y12 inhibitors vs. placebo
COVID-19 severe or critically